Moderna, the bloodied Covid-era prizefighter of the healthcare sector, stumbles toward its next earnings report on Thursday ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...

The HHS will invest $176 million in a mRNA vaccine from Moderna meant to protect against an avian influenza pandemic.

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

As the world marks World Immunization Week , attention turns once again to the lifesaving power of vaccines.Amid headlines ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Novavax faces uncertainty as FDA requests a new clinical trial for its COVID-19 vaccine, the last protein-based option in the ...

Such outperformance could have been... Moderna stock and other vaccine makers are under pressure after Peter Marks resigned from the FDA. Is MRNA stock a sell? Moderna (MRNA) doesn't possess the ...

HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine By Stephanie Brown HealthDay Reporter FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and ...